Molecular determinants that mediate selective activation of p38 MAP kinase isoforms

被引:187
|
作者
Enslen, H
Brancho, DM
Davis, RJ [1 ]
机构
[1] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA
[2] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA
关键词
MAP kinase; MKK3; MKK6; p38; signal transduction;
D O I
10.1093/emboj/19.6.1301
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p38 mitogen-activated protein kinase (MAPK) group is represented by four isoforms in mammals (p38 alpha, p38 beta 2, p38 gamma and p38 delta), These p38 MAPK isoforms appear to mediate distinct functions in vivo due, in part, to differences in substrate phosphorylation by individual p38 MAPKs and also to selective activation by MAPK kinases (MAPKKs), Here we report the identification of two factors that contribute to the specificity of p38 MAPK activation. One mechanism of specificity is the selective formation of functional complexes between MAPKK and different p38 MAPKs, The formation of these complexes requires the presence of a MAPK docking site in the N-terminus of the MAPKK. The second mechanism that confers signaling specificity is the selective recognition of the activation loop (T-loop) of p38 MAPK isoforms. Together, these processes provide a mechanism that enables the selective activation of p38 MAPK in response to activated MAPKK.
引用
收藏
页码:1301 / 1311
页数:11
相关论文
共 50 条
  • [31] p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation
    Stanton, LA
    Sabari, S
    Sampaio, AV
    Underhill, TM
    Beier, F
    BIOCHEMICAL JOURNAL, 2004, 378 : 53 - 62
  • [32] MAP kinase p38 is a novel target of CacyBP/SIP phosphatase
    Topolska-Wos, Agnieszka M.
    Rosinska, Sara
    Filipek, Anna
    AMINO ACIDS, 2017, 49 (06) : 1069 - 1076
  • [33] Inhibition of p38 MAP kinase activity enhances axonal regeneration
    Myers, RR
    Sekiguchi, Y
    Kikuchi, S
    Scott, B
    Medicherla, S
    Protter, A
    Campana, WM
    EXPERIMENTAL NEUROLOGY, 2003, 184 (02) : 606 - 614
  • [34] p38 MAP kinase regulates stem cell apoptosis in human hematopoietic failure
    Zhou, Li
    Opalinska, Joanna
    Verma, Amit
    CELL CYCLE, 2007, 6 (05) : 534 - 537
  • [35] Hydrogen-exchange mass spectrometry reveals activation-induced changes in the conformational mobility of p38α MAP kinase
    Sours, Kevin M.
    Kwok, Stan C.
    Rachidi, Thami
    Lee, Thomas
    Ring, Adam
    Hoofnagle, Andrew N.
    Resing, Katheryn A.
    Ahn, Natalie G.
    JOURNAL OF MOLECULAR BIOLOGY, 2008, 379 (05) : 1075 - 1093
  • [36] p38 MAP kinase -: a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability
    Issbrücker, K
    Marti, HH
    Hippenstiel, S
    Springmann, G
    Voswinckel, R
    Gaumann, A
    Breier, G
    Drexler, HCA
    Suttorp, N
    Clauss, M
    FASEB JOURNAL, 2002, 16 (14) : 262 - +
  • [37] Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation
    Borst, Oliver
    Walker, Britta
    Muenzer, Patrick
    Russo, Antonella
    Schmid, Evi
    Faggio, Caterina
    Bigalke, Boris
    Laufer, Stefan
    Gawaz, Meinrad
    Lang, Florian
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2013, 31 (06) : 914 - 924
  • [38] p38 MAP kinase activity modulates αβ T cell development
    Mulroy, T
    Sen, J
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2001, 31 (10) : 3056 - 3063
  • [39] Transient activation of P38 MAP kinase and up-regulation of Pim-1 kinase in cardiac hypertrophy despite no activation of AMPK
    Lei, Biao
    Chess, David J.
    Keung, Wendy
    O'Shea, Karen M.
    Lopaschuk, Gary D.
    Stanley, William C.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 45 (03) : 404 - 410
  • [40] Efficacy and gastrointestinal tolerability of ML3403, a selective inhibitor of p38 MAP kinase and CBS-3595, a dual inhibitor of p38 MAP kinase and phosphodiesterase 4 in CFA-induced arthritis in rats
    Koch, Diana A.
    Silva, Rodrigo B. M.
    de Souza, Alessandra H.
    Leite, Carlos E.
    Nicoletti, Natalia F.
    Campos, Maria M.
    Laufer, Stefan
    Morrone, Fernanda B.
    RHEUMATOLOGY, 2014, 53 (03) : 425 - 432